当前位置: 首页 > 新闻资讯 > 产品文献 > "酶免"产品文献：Integration of metabolomics and transcriptomics reveals the therapeutic mechanism underlying Chelidonium majus L. in the treatment of allergic asthma

"酶免"产品文献：Integration of metabolomics and transcriptomics reveals the therapeutic mechanism underlying Chelidonium majus L. in the treatment of allergic asthma

酶免官方商城 / 2026-04-27

文献标题

Integration of metabolomics and transcriptomics reveals the therapeutic mechanism underlying Chelidonium majus L. in the treatment of allergic asthma

文献作者

Renguang Wang、Xintong Sui、Xin Dong1,2, Liming Hu、Zhimeng Li、Hang Yu、Cuicui Li、Guoxin Ji、Shumin Wang

发表时间

2024年04月26日

文献影响因子

5.3

使用的酶免科研试剂盒产品名称

大鼠白细胞介素4（IL-4）ELISA科研试剂盒

大鼠白细胞介素6（IL-6）ELISA科研试剂盒

大鼠白细胞介素17（IL-17）ELISA科研试剂盒

下一篇:"酶免"产品文献：Immunoprotection of FliBc chimeric fiber2 fusion proteins targeting dendritic cells against Fowl adenovirus serotype 4 infection
上一篇:"酶免"产品文献：GA3-Induced SlXTH19 Expression Enhances Cell Wall Remodeling and Plant Height in Tomatoes

全部产品分类

浏览历史

"酶免"产品文献：Integration of metabolomics and transcriptomics reveals the therapeutic mechanism underlying Chelidonium majus L. in the treatment of allergic asthma